NCT05776602Completed
Fast Brain MRI in Children With Suspected Brain Tumor
Fast Brain MRI in Children With Suspected or Confirmed Brain Tumor
Source: ClinicalTrials.gov · Last updated 2 Jun 2026
Brief summary (registry, in English)
This study aims to assess the diagnostic performance of a new fast MRI sequence named Neuromix compared to routine clinical MRI for brain tumor in pediatric patients
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 32 (actual)
- First submitted
- 22 Feb 2023
- Start date
- 1 May 2023
- Primary completion date
- 30 Jul 2025
- Lead sponsor
- Karolinska University Hospital
- Diseases
- Childhood cancers
- NCT number
- NCT05776602
What you commit to
- Study type: Observational
- Participants enrolled: 32
- From 1 May 2023 to the primary completion date, 30 Jul 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- MRI planned without sedation
- Aborted MR exam
- Unstable patient
Who the study is looking for
- Age 0-18 years.
- Pediatric subjects with diagnosed or suspected brain tumor
- Referral routine MRI study.
Age in the registry: 1 month to 18 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Karolinksa Universitetssjukhuset Coordinator of this site? Confirm its status | Stockholm | Sweden | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.